Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vessela Kristensen

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Cell Reports|July 12, 2016
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast CancerRobert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, et al.
Breast Cancer Research and Treatment|September 23, 2021
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptinNazli Bahrami, Shakila Jabeen, Andliena Tahiri, et al.
Radiology. Artificial Intelligence|February 5, 2025
Performance of Two Deep Learning-based AI Models for Breast Cancer Detection and Localization on Screening Mammograms from BreastScreen NorwayMarit A Martiniussen, Marthe Larsen, Tone Hovda, et al.
Breast Cancer Research : BCR|January 17, 2007
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomasStephen J Chanock, Laurie Burdett, Meredith Yeager, et al.
Breast Cancer Research : BCR|April 18, 2015
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TFMari Tinholt, Hans Kristian Moen Vollan, Kristine Kleivi Sahlberg, et al.
Oncoimmunology|January 14, 2026
Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypesLilly Anne Torland, Jürgen Geisler, Youness Azimzade, et al.
Molecular Cancer Research : MCR|October 30, 2014
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53David Quigley, Laxmi Silwal-Pandit, Ruth Dannenfelser, et al.
Molecular Oncology|January 8, 2011
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancerJo Anders Rønneberg, Thomas Fleischer, Hiroko Kato Solvang, et al.
Molecular Oncology|November 26, 2015
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosisMaria Moksnes Bjaanæs, Thomas Fleischer, Ann Rita Halvorsen, et al.
Cancer Research|July 14, 2016
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma PatientsMev Dominguez-Valentin, Andrea Gras Navarro, Aminur Mohummad Rahman, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Cell Reports|July 12, 2016
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast CancerRobert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, et al.
Breast Cancer Research and Treatment|September 23, 2021
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptinNazli Bahrami, Shakila Jabeen, Andliena Tahiri, et al.
Radiology. Artificial Intelligence|February 5, 2025
Performance of Two Deep Learning-based AI Models for Breast Cancer Detection and Localization on Screening Mammograms from BreastScreen NorwayMarit A Martiniussen, Marthe Larsen, Tone Hovda, et al.
Breast Cancer Research : BCR|January 17, 2007
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomasStephen J Chanock, Laurie Burdett, Meredith Yeager, et al.
Breast Cancer Research : BCR|April 18, 2015
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TFMari Tinholt, Hans Kristian Moen Vollan, Kristine Kleivi Sahlberg, et al.
Oncoimmunology|January 14, 2026
Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypesLilly Anne Torland, Jürgen Geisler, Youness Azimzade, et al.
Molecular Cancer Research : MCR|October 30, 2014
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53David Quigley, Laxmi Silwal-Pandit, Ruth Dannenfelser, et al.
Molecular Oncology|January 8, 2011
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancerJo Anders Rønneberg, Thomas Fleischer, Hiroko Kato Solvang, et al.
Molecular Oncology|November 26, 2015
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosisMaria Moksnes Bjaanæs, Thomas Fleischer, Ann Rita Halvorsen, et al.
Cancer Research|July 14, 2016
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma PatientsMev Dominguez-Valentin, Andrea Gras Navarro, Aminur Mohummad Rahman, et al.
Pageof 10